TABLE 1.
Metastatic NET Patient Characteristics (N = 28)
| Age of diagnosis, median (range), y | 56 (35–69) |
| Sex, % | |
| Female | 50 |
| Male | 50 |
| Primary NET Location, % | |
| Pancreas | 46 |
| Small intestine | 29 |
| Lung | 14 |
| Unknown | 7 |
| Colon | 4 |
| NET Functionality, % | |
| Non-functional | 71 |
| Carcinoid syndrome | 14 |
| Gastrinoma | 7 |
| Glucagonoma | 4 |
| Insulinoma | 4 |
| NET Grade, % | |
| Grade I | 18 |
| Grade II | 46 |
| Grade III | 25 |
| Unknown | 11 |
| Metastasis location at the start of PRRT, % | |
| Liver | 93 |
| Lymph nodes | 68 |
| Bone | 29 |
| Lung | 18 |
| Other | 18 |
| Liver tumor burden, % | |
| <25% | 80 |
| 25% – 49% | 12 |
| 50% – 74% | 4 |
| ≥75% | 4 |